Dr. Joshi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2900 W Cypress Creek Rd
Ste 1
Fort Lauderdale, FL 33309Phone+1 954-977-0192Fax+1 954-977-0197
Education & Training
- University of South Florida MorsaniResidency, Ophthalmology, 2007 - 2010
- Rutgers Health/Monmouth Medical CenterInternship, Internal Medicine, 2006 - 2007
- Drexel University College of MedicineClass of 2006
Certifications & Licensure
- FL State Medical License 2008 - 2025
- GA State Medical License 2024 - 2025
- American Board of Ophthalmology Ophthalmology
Clinical Trials
- A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O With Ranibizumab in Subjects With wAMD Start of enrollment: 2021 Jul 01
Roles: Contact
Publications & Presentations
PubMed
- 10 citationsIntravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial.David M Brown, David S Boyer, Diana V Do, Charles C Wykoff, Taiji Sakamoto
Lancet. 2024-03-23 - 7 citationsEfficacy and Safety of Brolucizumab for Diabetic Macular Edema: The KINGFISHER Randomized Clinical Trial.Rishi P Singh, Mark R Barakat, Michael S Ip, Charles C Wykoff, David A Eichenbaum
JAMA Ophthalmology. 2023-12-01 - 13 citationsFaricimab Effectively Resolves Intraretinal Fluid and Preserves Vision in Refractory, Recalcitrant, and Nonresponsive Neovascular Age-Related Macular Degeneration.Anny M Cheng, Sunir Joshi, Raphael G Banoub, Jackson Saddemi, Kakarla V Chalam
Cureus. 2023-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: